Finafloxacin

	File:Finafloxacin.svg
Systematic (IUPAC) name
	8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Clinical data
Trade names	Xtoro
Identifiers
CAS Number	209342-40-5
PubChem	CID: 11567473
ChemSpider	9742243
ChEBI	CHEBI:85176
ChEMBL	CHEMBL1908370
Chemical data
Formula	C20H19FN4O4
Molecular mass	398.39 g/mol
	SMILES C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O ;
	InChI InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1 ; Key:FYMHQCNFKNMJAV-HOTGVXAUSA-N ;

Finafloxacin (Xtoro) is a fluoroquinolone antibiotic. In the United States, it is approved by the Food and Drug Administration to treat acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.^[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.